Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NAD Could Jog Cognitive Benefit Supplement Firm's Memory With FTC Call

This article is powered by The Rose Sheet

Executive Summary

NAD refers UltraMax Health's supplement claim to the FTC after it fails to provide substantiation. CRN emphasizes claims alone are not the problem, but the firm's failure to provide substantiation.


Related Content

Avantius Launches Supplement After Study Finds Formulation Slowed Alzheimer’s Progression
'Enhanced Brain Function' Supplement Sales Only A Memory After NAD Review
Supplement Claims Targeting Elderly, Weight Conscious Top FTC Priorities
FTC Enforcement Hangs Over Memory Product Firm After Overlooking NAD Review
American Dream's Nightmare Ends, But It Doubts NAD Standard For Claims
Complaint Reminds CVS: No Support For Memory Claim In Fish Oil Study
Sports Nutrition Products Mark Start Of FDA’s Picamilon Enforcement
Industry Roundup: FTC Enforcement, Herbalife Manufacturing, Swanson Health ‘Facts’
Supplement Claims For Autism Treatment Could Ring A Bell At FTC





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts